Aspirin’s Potential in Fighting Ovarian Cancer
Every year, approximately 20,000 women in the United States receive a devastating diagnosis of ovarian cancer. However, recent studies suggest that aspirin may hold promise in reducing the risk of this deadly disease. By inhibiting the production of a substance that promotes platelet stickiness, aspirin plays a pivotal role in impeding tumor growth. Additionally, aspirin’s anti-inflammatory properties contribute to a decreased risk of cancer overall. While scientists continue to investigate the mechanism behind aspirin’s protective effects against ovarian cancer, the findings thus far are encouraging.
Fights Colorectal and Gastrointestinal Cancer
Colorectal cancer, also known as colon cancer or rectal cancer, is a type of cancer that affects the colon and rectum. Numerous studies have shown that taking aspirin can significantly reduce the risk of developing colorectal cancer. Additionally, aspirin has also been found to have positive effects on gastrointestinal cancer. This type of cancer affects various parts of the gastrointestinal tract, including the stomach, pancreas, small and large intestine, rectum, and anus. It is important to note that individuals between the ages of 50 to 60 are at the highest risk of developing gastrointestinal cancer.